Evidence map›Paper›PMID 38087147›Full record

ReviewJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2024

Technological advances in ventricular tachycardia catheter ablation: the relentless quest for novel solutions to old problems.

Paolo Compagnucci, Yari Valeri, Sergio Conti, Giovanni Volpato, Laura Cipolletta, Quintino Parisi, Leonardo D'Angelo, Francesca Campanelli, Laura Carboni, Giuseppe Sgarito and 3 more

Abstract readReviewCase Reports
PubMed Publisher
In one paragraph

Review in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Ventricular pulsed field ablation from bench to bedside: preclinical and clinical evidence from a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Fascicular tachycardia ablation using optrell mapping catheter: a case report.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  7. Article
  8. Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias.Journal of cardiovascular development and disease · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Paolo CompagnucciCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy. paolocompagnucci1@gmail.com.ORCID http://orcid.org/0000-0003-1924-6548
Yari ValeriCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
Sergio ContiDepartment of Cardiology, Electrophysiology Unit, ARNAS Civico - Di Cristina - Benfratelli, Palermo, Italy.
Giovanni VolpatoCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
Laura CipollettaCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
Quintino ParisiCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
Leonardo D'AngeloCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
Francesca CampanelliCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
Laura CarboniCardiac Surgery Anesthesia and Critical Care Unit, University Hospital "Ospedali Riuniti,", Ancona, Italy.
Giuseppe SgaritoDepartment of Cardiology, Electrophysiology Unit, ARNAS Civico - Di Cristina - Benfratelli, Palermo, Italy.
Andrea NataleDepartment of Biomedical Sciences and Public Health, Marche Polytechnic University, Via Conca 71, 60126, Ancona, Italy.
Michela CasellaCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
Antonio Dello RussoCardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
Marche Polytechnic University · ITAzienda Ospedaliero Universitaria Ospedali Riuniti · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral novel technologies allowing catheter ablation (CA) with a favorable safety/efficacy profile have been recently developed, but not yet extensively clinically tested in the setting of ventricular tachycardia CA.

methodsIn this technical report, we overview technical aspects and preclinical/clinical information concerning the application of three novel CA technologies in the ventricular milieu: a pulsed field ablation (PFA) generator (CENTAURI™, Galaxy Medical) to be used with linear, contact force-sensing radiofrequency ablation catheters; a contact force-sensing radiofrequency ablation catheter equipped with six thermocouples and three microelectrodes (QDOT Micro™, Biosense-Webster), allowing high-resolution mapping and temperature-controlled CA; and a flexible and mesh-shaped irrigation tip, contact force-sensing radiofrequency ablation catheter (Tactiflex, Abbott). We also report three challenging VT cases in which CA was performed using these technologies.

resultsThe CENTAURI system was used with the Tacticath™ (Abbott) ablation catheter to perform ventricular PFA in a patient with advanced heart failure, electrical storm, and a deep intramural septal substrate. Microelectrode mapping using QDOT Micro™ helped to refine substrate assessment in a VT patient with congenitally corrected transposition of the great arteries, and allowed the identification of the critical components of the VT circuit, which were successfully ablated. Tactiflex™ was used in two challenging CA cases (one endocardial and one epicardial), allowing acute and mid-term control of VT episodes without adverse events.

conclusionThe ideation and development of novel technologies initially intended to treat atrial arrhythmias and successfully implemented in the ventricular milieu is contributing to the progressive improvement in the clinical benefits derived from VT CA, making this procedure key for successful management of increasingly complex patients.

Indexed as

Catheter AblationEquipment DesignTachycardia, VentricularAgedFemaleHumansMaleMiddle AgedTreatment OutcomeCatheter ablationCENTAURI™Pulsed field ablationQDOT Micro™TactiFlex™Ventricular tachycardia

Identifiers

PMID38087147
OpenAlexW4389640059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.